Literature DB >> 7376068

Neuroma of the cavernous sinus.

O Schubiger, A Valavanis, J Hayek, K Dabir.   

Abstract

A case of a surgically verified parasellar neuroma is presented. Despite clinical and radiological evidence for the origin of the tumor to be the trochlear or oculomotor nerves, an operation revealed a neuroma originating from the cavernous sinus, but exact identification of the origin of the tumor was not possible. The radiologic findings including polytomography, angiography and computed tomography are presented. The clinical and radiological differentiation between this case and typical neuromas of the gasserian ganglion are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7376068

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

1.  Exophytic third nerve schwannoma mimicking a mesial temporal intra-axial lesion: case report.

Authors:  Biji Bahuleyan; Girish R Menon; Mradul Sharma; Suresh Nair
Journal:  Childs Nerv Syst       Date:  2011-12-02       Impact factor: 1.475

2.  Schwannoma of extraocular nerves: survey of literature and case report of an isolated third nerve schwannoma.

Authors:  W Niazi; J E Boggan
Journal:  Skull Base Surg       Date:  1994

3.  Sphenocavernous and infratemporal trigeminal neurinomas: surgical series of 15 cases.

Authors:  A Visot; P Derome; J L De Leon
Journal:  Skull Base Surg       Date:  1992

4.  Cavernous haemangioma in the oculomotor nerve. A case report.

Authors:  T Yamada; S Nishio; M Matsunaga; M Fukui; I Takeshita
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

Review 5.  Management of oculomotor nerve schwannomas in two different locations: surgical nuances and comprehensive review.

Authors:  Sunil V Furtado; Alangar S Hegde
Journal:  Neurosurg Rev       Date:  2011-07-26       Impact factor: 3.042

6.  Oculomotor nerve schwannoma associated with acute hydrocephalus: case report.

Authors:  Keiya Iijima; Masahiko Tosaka; Takuro Nagano; Hiroyuki Yaoita; Nozomi Matsumura; Yoichi Nakazato; Yuhei Yoshimoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-20       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.